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CAPSULE 
Background: The human 2-oxoglutarate 
dehydrogenase complex, comprising E1o, E2o, E3 
components, catalyzes conversion of 2-
oxoglutarate to succinyl-CoA.  
Results: Human E1o generates both a thiamin-
enamine-derived radical and the reactive oxygen  
species, superoxide and hydrogen peroxide.  
Conclusion: Human E1o produces reactive 
oxygen species at a rate of < 1% of succinyl-CoA  
under physiological conditions.  
Significance: Novel discovery that the 5carboxyl 
group affects enzymatic reactivity of 2-
oxoglutarate.  
 
ABSTRACT   
Herein are reported unique properties of the 
human 2-oxoglutarate dehydrogenase 
multienzyme complex (OGDHc), a rate-limiting 
enzyme in the Krebs (citric acid) cycle. (a) 
Functionally competent 2-oxoglutarate dehydro-
genase (E1o-h) and dihydrolipoylsuccinyl trans-
ferase (E2o-h) components have been expressed 
according to kinetic and spectroscopic evidence. 
(b) A stable free radical, consistent with the C2-
(C2-hydroxy)--carboxypropylidene thiamin 
diphosphate (ThDP) cation radical was detected by 
electron spin resonance on reacting of the E1o-h 
with 2-oxoglutarate (OG) by itself or when 
assembled from individual components into 
OGDHc. (c) An unusual stability of the E1o-h-
bound C2-(2-hydroxy)--carboxy-propylidene 
thiamin diphosphate (the „ThDP-enamine‟/C2-
carbanion, the first post-decarboxylation 
intermediate) was observed, likely stabilized by 
the 5-carboxyl group of OG, not reported before. 
(d) The reaction of OG with the E1o-h gave rise to 
superoxide anion and hydrogen peroxide (reactive 
oxygen species, ROS).  (e) The relatively stable 
enzyme-bound enamine is the likely substrate for 
oxidation by O2, leading to the superoxide anion 
radical (in d) and the radical (in b). (f)The specific 
activity assessed for ROS formation compared to 
the NADH (overall complex) activity, as well as 
the fraction of radical intermediate occupying 
active centers of E1o-h are consistent with each 
other, and indicate that radical/ROS formation is 
an „off-pathway‟ side reaction comprising less 
than 1% of the „on-pathway‟ reactivity. Yet, the 
nearly ubiquitous presence of OGDHc in human 
tissues, including the brain, makes these findings 
of considerable importance in human metabolism, 
and perhaps disease.  
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INTRODUCTION. 
The 2-oxo acid dehydrogenase multienzyme 
complexes have roles at key junctions in human 
metabolism (1). While the pyruvate 
dehydrogenase complex (PDHc) produces acetyl-
CoA at the entry to the citric acid cycle, the 2-
oxoglutarate dehydrogenase complex (OGDHc, 
also known as ketoglutarate dehydrogenase 
complex) is a rate-limiting enzyme in the citric 
acid cycle and produces succinyl-CoA by 
oxidative decarboxylation of 2-oxoglutarate (OG, 
also known as -ketoglutarate). The OGDHc is a 
multienzyme complex that contains multiple 
copies of three component enzymes (Scheme 1): a 
thiamin diphosphate (ThDP) dependent 2-
oxoglutarate dehydrogenase (E1o, EC 1.2.4.2), 
dihydrolipoylsuccinyl transferase (E2o, EC 
2.3.1.61), and dihydrolipoyl dehydrogenase (E3, 
EC 1.8.1.4). The E1o and E2o carry out the 
principal reactions for succinyl-CoA formation 
while the E3 reoxidizes dihydrolipoamide-E2o to 
lipoamide-E2o, the redox cofactor covalently 
amidated onto a single lysine residue of the E2o 
components. The OGDHc catalyzes one of the 
rate-limiting steps in the citric acid cycle (1-3), 
which is the common pathway for oxidation of 
fuel molecules, including carbohydrates, fatty 
acids and amino acids. Reduced activities of key 
citric acid cycle enzymes, including OGDHc 
activity has been linked to neurodegenerative 
disorders, such as Alzheimer‟s and Parkinson‟s 
disease and oxidative damage (4-6).   
    Functionally competent E1o-h and E2o-h 
components were created for the first time. There 
are no structures for these components, or for that 
matter of any intact E2 component from any 
source. Structures are available for the E3 
component (7-12) and for N-terminally truncated 
(some 77 amino acids) E. coli 2-oxoglutarate 
dehydrogenase ( (E1o-ec) (13). The availability of 
the human E1o and E2o components enabled us to 
characterize longer-lived ThDP-bound inter-
mediates on E1o-h.  
   While typical ThDP-assisted decarboxylation 
mechanisms are ionic in nature, there are 
important known exceptions: (a) pyruvate-
ferredoxin oxidoreductase (PFOR) (14,15) utilizes 
three tandem Fe4S4 clusters to oxidize the enamine 
intermediate to acetyl-CoA, (b) pyruvate oxidase 
(POX) produces acetate in E. coli and acetyl 
phosphate in Lactobacillus plantarum, and both 
PFOR and POX (16) have been shown to support 
a post-decarboxylation related radical that has spin 
density not only at the C2 atom, but also around 
the thiazolium ring (henceforth the ThDP-enamine 
radical) (14-17). The observation of a similar 
radical on E1o-ec (18) raised the possibility that 
such a radical also exists on the E1o-h. There have 
been several reports that mammalian OGDHc 
could be a major source of the reactive oxygen 
species, superoxide radical anion and hydrogen 
peroxide (ROS) in isolated brain and skeletal 
muscle mitochondria (5,19), and in the isolated 
synaptosomes (6), as was also confirmed with the 
isolated mammalian OGDHc (5,6). Based on 
experiments with spin-trapping techniques, and 
using the isolated mammalian OGDHc with 
modified flavin cofactor of E3, it was concluded 
that E3-bound FAD is responsible for the 
production of  radical species by OGDHc (20). 
The above conclusions were supported further by 
experiments with brain mitochondria isolated from 
E3-deficient mice that produce less H2O2 as 
compared with wild-type mice (5). Based on these 
studies, ROS generation by OGDHc was attributed 
to the E3 component (6, 21-24). It has been 
documented that OGDHc could produce H2O2 in 
the forward physiological reaction by oxidation of 
OG in the presence CoA, and in the reverse 
reaction at high NADH/NAD
+
 ratio (no OG is 
needed). With the E3 component being shared by 
OGDHc,  PDHc and branched-chain 2-oxoacid 
dehydrogenase complex (BCODHc), OGDHc was 
reported to produce H2O2 at about twice the rate 
produced by PDHc, four times the rate produced 
by BCODHc in isolated skeletal muscle 
mitochondria, and the rates were dependent on 
concentration of their specific substrates rather 
than on NADH/NAD ratio (19).   
    At the same time, it has recently been suggested 
that isolated E1 components of the OGDHc and 
PDHc could provide intermediates leading to ROS 
production (19). With individually expressed 
human E1o, E2o and E3, we have an opportunity 
to investigate the redox chemistry on human 
OGDHc. We here demonstrate that E1o-h gives 
rise to a stable ThDP-derived radical  
corresponding to the C2(2-hydroxy)--carboxy-
propylidenethiamin diphosphate cation radical 
(ThDP-enamine radical), also detected on POX 
and PFOR and on the E1o-ec earlier by Electron 
Paramagnetic Resonance (EPR) spectroscopy (18). 
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Circular dichroism (CD) and VIS spectroscopic 
evidence was found for a stable E1o-h-bound 
„enamine‟/C2-carbanion (the first ThDP-bound 
post-decarboxylation intermediate in Scheme 1) 
C2-(2-hydroxy)--carboxypropylidenethiamin 
diphosphate (ThDP-enamine), thereby completing 
description of the chemistry in Equation 1: 
                                CO
2                       
O
2
E1o-h+ThDP+OG            enamine           ThDP-enamine-derived radical + O
2
.-     
    (1)
 
The relatively stable enzyme-bound enamine is the 
likely substrate for oxidation by O2, leading to the 
generation of superoxide anion and ThDP-derived 
radical. 
    The results inform that E1o-h does produce both 
the ThDP-enamine radical and superoxide/H2O2. 
Generation of superoxide/H2O2 by E1o-h may 
have pathological relevance especially under 
conditions genetic deficiencies of the E2o-h due to 
mutations (25), polymorphism (26)
 
or down-
regulation (27,28). In cultured human embryonic 
kidney cells the reduction in E2o-h level 
augmented ROS generation and cell death (27). 
E2o-h deficiency also elevated the amyloid plaque 
burden, the levels of A oligomers and 
nitrotyrosine, and the occurrence of spatial 
learning and memory deficits in mice (29), while 
decreased OGDHc activity in general and resultant 
prolonged oxidative stress are known to be part of 
the pathogenesis in Alzheimer's disease (AD) (30-
32). 
    While the E3 component is common to all 2-
oxo acid dehydrogenase complexes in a particular 
cell type, the chemistry on E1o is apparently 
significantly different from that on the PDHc. The 
findings with both human and bacterial E1o‟s 
place on firm ground the dramatic differences 
between the pyruvate and OG-derived 
intermediates on ThDP, and all point to, and are 
consistent with a role of the side chain carboxyl 
group (carbon 5) in the series of reactions taking 
place on ThDP.  
 
EXPERIMENTAL PROCEDURES  
    Reagents. ThDP, NAD
+
, CoA, DTT, DL--
lipoic acid, IPTG, Thiamin.HCl, and 
benzamidine.HCl were from U.S. Biochemical 
Corp.  2, 6-Dichlorophenolindophenol (DCPIP) 
was from Sigma-Aldrich, Amplex Red fluorescent 
dye was from Molecular Probes, Eugene, OR, 
(USA).  
   Protein Expression and Purification. Expression 
and purification of the E. coli E1o-ec, E2o-ec, and 
E3-ec was as reported earlier (33).  
   Construction of Plasmid and Expression and 
Purification of E1o-h and E2o-h.The genes 
encoding his6.tag E1o-h and his6.tag E2o-h were 
synthesized by DNA2.0, Inc. (Menlo Park, CA). 
The E1o-h gene optimized for expression in E. 
coli cells and E2o-h gene were inserted into pET-
22b (+) and pET-15b vectors, respectively, and the 
resulting plasmids were expressed in BL21 (DE3) 
cells. Cells were grown in LB medium 
supplemented with 50 g /mL of ampicillin 
containing 1 mM MgCl2 and 0.5 mM thiamin for 
E1o-h expression or 0.3 mM DL--lipoic acid for 
E2o-h expression. Protein expression was induced 
by 0.5 mM IPTG for 5 h at 37 
o
C for E2o-h and 
for 15 h at 25 
o
C for E1o-h. Cells were washed 
with 0.20 M KH2PO4 (pH 7.0) containing 0.15 M 
NaCl and stored at -20 
o
C. The harvested cells 
were dissolved in 50-70 mL of 50 mM KH2PO4 
(pH 7.5) containing 0.3 M KCl, 2.0 mM ThDP, 
5.0 mM MgCl2 and one protease inhibitor cocktail 
tablet (Roche Applied Science). Cells were treated 
with lysozyme (0.60 mg/ml) at 4 
o
C for 20 min 
and were disrupted using a sonic dismembrator. 
The clarified lysate was loaded onto Ni Sepharose 
column (GE Healthcare) equilibrated with 50 mM 
KH2PO4 containing 0.30 M KCl, 0.50 mM ThDP, 
1.0 mM MgCl2 and 30 mM imidazole (pH 7.5). 
The E1o-h was eluted with 300 mM imidazole in 
the same buffer. The E1o-h was dialyzed against 
50 mM KH2PO4 (pH 7.5) containing 0.30 M NaCl, 
0.50 mM ThDP, 2.0 mM MgCl2 and 1.0 mM 
benzamidine.HCl at 4 
o
C for 15 h. The protein was 
concentrated and buffer was exchanged to 50 mM 
HEPES (pH 7.5) containing 0.15 M NaCl, 0.50 
mM ThDP, 1.0 mM MgCl2 and 1 mM 
benzamidine.HCl and was stored at -20 
o
C.  The 
his6-tag E2o-h was purified similarly to that 
reported for E2p-ec (34).  
    Expression and Purification of E3-h.   For 
expression and purification of E3h E. coli M15 
cells were used and the pQE-9 vector with the 
gene encoding E3-h as reported earlier (35) with 
some modifications. Cells were grown in LB 
medium supplemented with 100 g/mL of 
ampicillin and E3-h expression was induced by 0.5 
mM IPTG at 25 
o
C for 15 h. E3-h was purified 
using a Ni Sepharose column (GE Healthcare). 
The protein was bound to the Ni Sepharose 
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column in the presence of 30 mM imidazole in 50 
mM KH2PO4 (pH 7.5) containing 0.3 M KCl and 
was eluted with 300 mM imidazole in 50 mM 
KH2PO4 (pH 7.5) containing 0.3 M KCl. Protein 
was concentrated and the buffer was exchanged to 
50 mM KH2PO4 (pH 7.5) containing 0.20 M KCl, 
1.0 mM benzamidine.HCl and 25 M FAD. The 
protein was stored at -80 
o
C. 
    Enzyme Activity Measurements; Overall Activity 
upon Reconstitution of OGDHc-h from Individual 
Components. For reconstitution of OGDHc-h from 
its individual components, E1o-h (0.13 mg; 4.6 
M subunits) was incubated for 30 min with E2o-
h (0.65 mg; 60 M subunits) and E3-h (0.65 mg; 
52 M subunits) with mass ratio (g: g: g) of 
1:5:5 in 0.25 mL of 50 mM KH2PO4 (pH 7.5) 
containing 0.50 mM ThDP, 1.0 mM MgCl2, 0.15 
M NaCl and 1.0 mM benzamidine.HCl at 25 
o
C. A 
0.010 mL aliquot of the reaction mixture was 
withdrawn after 1 h incubation to start the 
reaction. The stoichiometry of components used 
for activity measurement was chosen from kinetic 
experiments where at constant concentrations of 
E1o-h subunits (0.046 M) and E3-h subunits 
(0.52 M), the concentration of E2o-h subunits 
was varied (0.059-0.80 M) leading to S0.5,E2o-h = 
0.18 ± 0.08 . In a similar experiment with 
varied concentrations of E3-h subunits (0.026-0.53 
M) and constant concentrations of E1o-h (0.046 
M) and E2o-h (0.24 M) subunits, an S0.5, E3-h of 
0.17 ± 0.02 M was calculated. The reaction 
medium contained in 1.0 mL: 0.10 M Tris HCl 
(pH 7.5), 0.50 mM ThDP, 2.0 mM MgCl2, 2.0 mM 
OG, 2.0 mM DTT, 5 mM NAD
+
, 0.1-0.20 mM 
CoA at 37 
o
C.  The reaction was initiated by 
addition of CoA and OGDHc. Steady-state 
velocities were taken from the linear portion of the 
progress curve. One unit of activity is defined as 
the amount of NADH produced (mol.min-1.mg 
E1o
-1
).   
    E1o-h Specific Activity. The E1o-h specific 
activity was measured in the reaction medium with 
the external oxidizing agent 2, 6-
dichlorophenolindophenol (DCPIP, ref. 36) at 600 
nm in the reaction medium contained in 1 mL: 50 
mM KH2PO4 (pH 7.0), 0.50 mM ThDP, 1.0 mM 
MgCl2, 2 mM OG and DCPIP (0.08 mM) at 37 
o
C.  
The reaction was initiated by addition of 0.01-
0.015 mg of E1o-h. Steady-state velocities were 
taken from the linear portion of the progress curve 
recorded at 600 nm. One unit activity is defined as 
the amount of reduced DCPIP produced 
(mol.min-1.mg E1o-h-1).  
   Superoxide Production by E1o-h.  Superoxide  
production  by E1o-h was measured via reduction 
of  acetylated cytochrome c (cyt c), as described 
earlier, with minor modifications, at pH 6.3 where 
the sensitivity of the method was optimal (22,37-
40). The initial reaction velocity was measured 
and converted to generated superoxide amount 
(nmol) .min
-1
.mg E1o-h 
-1
 taking into account that 
the stoichiometry of the reaction between cyt c and 
superoxide is 1:1 (37). Assay conditions were the 
following in a 200 l final volume in a microtiter 
plate-based experiment: 50 mM KH2PO4, (pH 
6.3),  0.2 mM ThDP, 1 mM Mg
2+
, 0.1 mM CoA, 2 
mM OG, 50 M cyt c (all in final concentrations), 
and 64.44 g E1o-h. The concentration of cyt c 
was chosen to determine a linear dynamic range 
for the measurements (22,37). Protein 
concentration was determined by the Bradford 
method (41). The reaction was initiated by the 
addition of OG (10 L, 5%) after 15 min 
incubation at 37 
o
C and after the base line was 
stabilized. Measurements were carried out at the 
λmax of 550 nm of the reduced form of  acetylated 
cyt c in EIA/RIA 96-well, flat-bottom, polystyrene 
plates (Corning, Lowell, MA, USA) using a 
Spectramax M2 (Molecular Devices, Sunnyvale, 
CA, USA) or a Victor 3 (Perkin Elmer, Waltham, 
MA, USA) multilabel counter spectrophoto-
meter/fluorimeter. Extinction coefficient of 10,170 
M
-1
cm
-1
 (λmax of 550 nm) was determined for the 
fully reduced cyt c by sodium dithionite under the 
assay conditions. The superoxide dismutase from 
bovine erythrocytes (SOD) was used to verify that 
cyt c reduction was indeed caused by superoxide 
generated by the E1o-h; 100 U SOD was added to 
200 L of reaction mixture, where applied.     
H2O2 Production by E1o-h. To detect H2O2 
generated by E1o-h, the Amplex Red fluorescent 
dye (Molecular Probes, Eugene, OR, USA) was 
used as reported earlier (6,21,42). In the presence 
of horseradish peroxidase (HRP), the Amplex Red  
reacts with H2O2 with a 1:1 stoichiometry 
producing highly fluorescent resorufin. 
Fluorescence was detected in a PTI Deltascan 
fluorescence spectrophotometer (Photon 
Technology International, PTI, Lawrenceville, NJ, 
USA); the excitation wavelength was 550 nm, and 
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the fluorescence emission was detected at 585 nm. 
A calibration curve was generated with known 
amounts  of H2O2 at the end of each experiment. 
The reaction was initiated by the addition of the 
E1o-h or OG after 15 min incubation at 37 
o
C of 
Amplex Red and HRP  and after the stabilization 
of the fluorescence signal, generally 100-200 s 
after  addition of all  required  components. For 
calculation of the reaction rate, slopes of the 
curves detected in the absence of E1o-h were 
subtracted from the initial slopes measured in the 
presence of both E1o-h and OG. The reaction 
assay in 2 ml of 50 mM KH2PO4 (pH 6.3 or 7.3) 
contained the following components at the final 
concentrations: 1 unit HRP, 1 M Amplex Red, 
0.1 mM EGTA, 0.2 mM ThDP, 0.4 mM ADP, 1 
mM Mg
2+
, 0.12 mM CoA, 1 mM OG, and 64.4 g 
E1o-h, at 37 
o
C under continuous stirring. 
Statistical differences were evaluated using the 
Excel program with two-tailed Student‟s t-tests 
assuming unequal variances and were accepted to 
be significant when p<0.05.  
Stopped-flow CD Spectroscopy. Kinetic traces 
were recorded on a Pi*-180 stopped-flow CD 
spectrometer (Applied Photophysics, U.K.) using 
10 mm path length. The intermediates seen on 
steady-state CD at ~298 and ~352 nm were 
detected on stopped-flow CD at 297 nm and 365 
nm respectively, as dictated by the high sensitivity 
of the lamp at those wavelengths. Data from six or 
seven repetitive shots were averaged and fit to the 
appropriate equations (see Figure Legends). For 
pre-steady state rate determination of ThDP-bound 
intermediates, E1o-ec (38 µM concentration of 
active centers) in one syringe was mixed in the 
reaction cell with OG (4 mM) from the second 
syringe and  the reaction was  monitored at 297 
nm or 365 nm for 50 s  at 20 
o
C. For CD 
experiments at 365 nm in the absence and 
presence of enamine acceptors, E1o-ec (38 µM 
concentration of active centers) from one syringe 
was mixed with OG (200µM) placed in the second 
syringe and the reaction was monitored for 50 s at 
20 
o
C.  The alternative enamine acceptors, E2o-
ec
1-176 didomain (60 µM), DCPIP (50 µM) and 
glyoxylate (GA, 2 mM) were placed in the second 
syringe together with OG.  
    Rapid Chemical Quench and NMR Methods. 
The rapid reaction mixing experiments were 
carried out using a rapid chemical quench 
apparatus (Kintek RQF-3 model, Kintek Corp), 
and NMR spectra were acquired on a Varian 
INOVA 600 MHz instrument using gradient 
Carbon Homonuclear Single Quantum Coherence 
(gCHSQC, to enable observation of only those 
protons attached to 
13
C nuclei, ref 43). The water 
signal was suppressed by pre-saturation. For 
reconstitution with [C2,C6‟-
13
C2]ThDP, the E1o-ec 
(0.12 mM, free of ThDP) was incubated  with 1 
equivalent of [C2,C6‟-
13
C2]ThDP (0.12 mM) and 5 
mM MgCl2 for 30 min on ice. [C2,C6‟-
13
C2]ThDP 
labeled E1o-ec was loaded into syringe A and OG 
was loaded into syringe B in a rapid chemical 
quench apparatus. A quench solution (12.5% TCA 
in 1M DCl/D2O) was loaded into syringe C. 
Enzyme and OG solutions were mixed rapidly in a 
1:1 volume ratio by computer controlled drive-
plate and incubated for predetermined times in a 
reaction loop. After this incubation period, the 
reaction mixture was mixed rapidly with quench 
solution from syringe C and the resulting mixture 
was collected. For longer time scales (>20s) the 
samples were assembled similarly into three 
different solutions. Next, equal volumes of 
[C2,C6‟-
13
C2]ThDP labeled E1o-ec (200 L)  and 
OG (200 L) were mixed in an Eppendorf  tube, 
and after predetermined times the reaction was 
stopped by addition of quench solution (200 L). 
The contents of the syringes in 20 mM KH2PO4 
(pH 7.4) were varied to monitor the following 
different reactions: 
   (1) For E1o-ec with OG single turnover, syringe 
A contained [C2,C6‟-
13
C2]ThDP labeled E1o-ec 
(115 µM concentration of active centers), syringe 
B contained  OG (20 mM).The reaction was 
performed for a time period of 10-2000 ms. 
   (2) For the E1o-ec and DCPIP reductase 
reaction, syringe A contained [C2,C6‟-
13
C2]ThDP 
labeled E1o-ec (115 µM concentration of active 
centers), syringe B contained  OG (20 mM) and  
DCPIP (8 mM). The reaction was performed for 
10-200 ms. 
   (3) For E1o-ec and succinic semialdehyde (SSA) 
reverse reaction, syringe A contained [C2,C6‟-
13
C2]ThDP labeled E1o-ec (115 µM concentration 
of active centers), syringe B contained  SSA (20 
mM). 
    The quenched reaction mixture was collected 
and centrifuged at 15,700 g for 20 min and the 
supernatant was separated and filtered through 
Gelman 0.45 µM discs, then the filtrate was 
analyzed by gCHSQC NMR  at 25 
o
C
2
. Using  
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[C2,C6‟-
13
C2]ThDP in conjunction with the 
gCHSQC method, enables observation of only 
those protons bound to 
13
C atoms, very useful for 
intermediate detection in the aromatic spectral 
region. The interpretation of NMR spectra were in 
analogy with observations made with pyruvate 
earlier (43). 
    Electron Paramagnetic Resonance Spectros-
copy. For sample preparation: (1) E1o-h (50 
mg/mL concentration of active centers = 0.449 
mM ) in 0.4 mL of 50 mM HEPES (pH 7.5) 
containing 0.15 M NaCl, 0.50 mM ThDP and 1.0 
mM MgCl2 was mixed with 10 mM OG at room 
temperature.  The mixture was immediately 
transferred into an EPR tube and was flash-frozen 
in liquid nitrogen within 40 s of mixing all 
components; (2) E1o-ec (0.150 mM concentration 
of subunits) in 0.20 mL of 50 mM Tris-HCl (pH 
7.4) containing 2 mM ThDP, 2 mM MgCl2 and 
10% glycerol was mixed with 10 mM OG or OA 
at  room temperature and was transferred into an 
EPR tube; (3) For OGDHc-h assembly, E1o-h, 
E2o-h and E3-h were mixed in 50 mM HEPES  
(pH 7.5) containing 0.50 mM ThDP, 1.0 mM 
MgCl2 and 0.15 M NaCl with 0.222 mM 
concentration of subunits for each protein (ratio of 
E1o-h:E2o-h:E3-h subunits = 1:1:1). Reaction was 
started by addition of 10 mM OG. After ~30 s, the 
samples were flash-frozen in liquid nitrogen and 
the sample was inserted into the EPR resonator. 
The following conditions were used for EPR 
experiments. X-band (9 GHz) EPR measurements 
were made using a Varian E-112 spectrometer 
interfaced to a PC using custom written software.  
A finger dewar filled with liquid nitrogen and 
inserted into a TE102 rectangular EPR cavity 
maintained the sample at 77 K throughout the 
measurements.  Spectrometer parameters used to 
acquire the spectrum in Fig. 4 are as follow: 
modulation amplitude, 5 G; microwave power, 
0.05 mW; receiver gain, 3.2 x 10
4
; microwave 
frequency, 9.119 GHz, scan time, 0.5 min; time 
constant 0.128 s; number of scans, 49.  The field 
was calibrated using a standard sample of Mn 
doped in MgO (44).  The concentration of the 
radical species was estimated by comparing the 
double integrated intensity of the radical signal to 
that of a 400 µMol Cu(II)-EDTA standard sample. 
Spectral simulations were carried out using 
previously described software (45) in which the 
Zeeman interaction is treated exactly and nuclear 
hyperfine coupling interactions are treated to first 
order.  Parameters used for the simulation 
displayed in Results and Discussion are as follow: 
principal g-values g1 = 2.008, g2 = 2.005, g3 = 
2.002; 
14
N (nuclear spin I = 1) hyperfine coupling 
principal values (in Gauss) = 1, 1, 13; unique 
principal value of 
14
N hyperfine coupling 
interaction oriented along g3; Four isotropic 
1
H 
hyperfine coupling interactions (in Gauss) = 5, 4, 3 
and 3; Gaussian broadening function = 2.5 G half-
width at half-height.   
    
RESULTS and DISCUSSION   
Functional Competence of the E1o-h.  Our 
interest in the catalytic mechanism of ThDP-
dependent enzymes, and the involvement of 
OGDHc in human pathology known in the 
literature, prompted us to synthesize genes 
expressing E1o-h and E2o-h. Since data on 
OGDHc reported in the literature are mostly 
limited by mammalian sources, this is the first 
report on OGDHc-h assembled from individual 
recombinant components that produce active 
OGDHc-h. The identity of E1o-h and E2o-h was 
confirmed by Fourier transform mass spectrometry 
(FT-MS) analysis of peptic peptides resulting from 
pepsin treatment of E1o-h and E2o-h components 
(see SI Tables S1 and S2). The functional 
competence of E1o-h and E2o-h was confirmed by 
the following experiments: 
(1) Kinetic studies. An E1o-h specific activity of 
1.78±0.40 mol.min-1.mg E1o-1 (kcat=6.7 s
-1
) was 
measured by monitoring the reduction of the 
external oxidizing agent 2,6-DCPIP  at 600 nm 
(36) in the assay containing E1o-h and OG as 
compared with 0.34 mol.min-1.mg E1o-1 reported 
by us earlier for E1o-ec (ref. 33, Table 1) (for 
composition of assay medium see Experimental 
Procedure). In this reaction, the enamine 
intermediate produced on E1o-h from OG, is 
oxidized by DCPIP with the formation of 
succinate and reduced DCPIP (36). While there is 
a recent report of the E1o-h specific activity of 
0.30 mol.min-1. mg protein-1, measured as the 
rate of carboligase reactivity with glyoxylate as an 
acceptor instead DCPIP, we cannot directly 
compare the results of the two assays (46).  
  An overall OGDHc activity of 7.86 ± 0.74 
mol.min-1.mg E1o-h-1 (kcat =30 s
-1
) was measured  
for E1o-h reconstituted with E2o-h and E3h 
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components once the stoichiometry of the 
components was optimized (for composition of 
assay medium and the stoichiometry of the 
components see Experimental Procedure and 
legend to Fig. 1). To our knowledge, this is the 
first report on successful expression of 
recombinant human E1o and E2o components that 
could be assembled into active OGDHc-h. As 
comparison, an E1o activity of 20 mol.min-1.mg 
E1o
-1
 within the isolated pig heart OGDHc was 
calculated (46) in good accord with our data above 
(7.86 ± 0.74 mol.min-1.mg E1o-h-1) and confirm 
functional competence of the recombinant E1o-h 
and E2o-h components.  
    We estimate a S0.5,OG of 0.15 mM for E1o-h in 
the overall OGDHc assay (Fig. 1-top), similar to 
that reported for mammalian OGDH complexes 
(47-52). Also, values of S0.5,OG of 30 M and 
S0.5,OG of 120 M were reported for OG binding in 
two active centers of human heart OGDHc with an 
overall OGDHc activity of ~ 6 mol.min-1.mg 
protein
-1
 (53).  
    The pH dependence of the overall OGDHc-h 
activity displayed a pH-independent plateau near 
physiological pH (6.5-7.5), but reduced activity 
with increasing pH, with an apparent pKa of 8.48 
(Fig. 1-bottom) that correlates well with the pH 
optimum of 6.65 over a relatively broad range (~2 
pH units) (51), and a pH optimum of 6.5-7.0
  
reported for mammalian OGDHc‟s (54). Our 
subsequent experiments were carried out in this 
pH-indepedent plateau region.  
(2) Circular dichroism studies with OG. CD 
titration of E1o-h by OG in the absence of E2o-h 
and E3 revealed the appearance of two CD bands 
(Fig. 2-top) similar to those observed with E1o-ec 
(Fig. 2-bottom) leading to the following 
conclusions: (i) a positive CD band at 302 nm, 
earlier assigned to the 1‟,4‟-iminopyrimidine 
tautomer (IP form) of either the first pre-
decarboxylation or the second post-
decarboxylation ThDP-bound intermediate (C2-
(-hydroxy)--carboxypropyl ThDP in Scheme 1), 
since it had been concluded that all ThDP 
intermediates with C2 tetrahedral substitution 
exist in their IP form at a pH near and above the 
pKa of the 4‟-aminopyrimidinium (APH
+
) 
conjugate acid form (55), and (ii) a positive CD 
band at 347 nm (Fig. 2) that could tentatively be 
assigned to the enamine intermediate (the first 
post-decarboxylation intermediate in Scheme 1). 
Both E1o-h CD bands displayed dependence on 
the concentration of OG resulting in a S0.5,OG of 
0.14 mM (302 nm) and S0.5,OG of 0.09 mM (347 
nm). Unlike on E1o-ec, according to the behavior 
of this CD band, this intermediate is not as 
stabilized on E1o-h as on E1o-ec, making its 
detection more difficult.  
(3) Circular dichorism studies on E1o-h with 
phosphonate and phosphinate analogues. 
Formation of the IP tautomer of ThDP-bound pre-
decarboxylation intermediate in the active centers 
of E1o-h was evident from CD spectra of E1o-h 
titrated by phosphonate analogues of OG: 
succinylphosphonate methyl ester (CD maximum 
at 296 nm, S 0.5, succinylphosphonate methyl ester = 48 ± 19 
M) and succinylphosphonate (CD maximum at 
304 nm), and also by acetylphosphinate, an 
analogue of pyruvate (CD maximum at 300 nm, 
S0.5, acetylphosphinate= 28 ± 2.6 M), known to be a 
potent inhibitor of ThDP-dependent decarboxyl-
ases (33,47,56-63). In addition, the CD spectra of 
all tested phosphonate analogues displayed a the 
negative CD band around 330 nm, earlier assigned 
at Rutgers to the Michaelis complex (64), 
suggesting half-of-the site reactivity with one 
active center filled with ThDP-bound pre-
decarboxylation intermediate and the second 
active center filled with Michaelis complex. Based 
on the data presented, we can conclude that: the 
tested phosphonate and phosphinate analogues 
bind in the active centers of E1o-h according to 
the CD bands formed at 300 nm, 302 nm and 304 
nm, respectively (Fig. 3 for an example), all 
assigned to a stable C2-tetrahedral pre-
decarboxylation intermediate analogues in their 
1‟,4‟-iminopyrimidinyl tautomeric forms as 
demonstrated earlier for  E1o-ec (33) and for E1p-
ec (61). The ability of E1o-h to form this 
intermediate confirms that E1o-h is folded 
correctly with ThDP in the active V conformation. 
Earlier the potency of succinylphosphonate 
inhibition of the OGDHc from bovine brain (47) 
and of E1o-ec (58) was demonstrated in kinetic 
experiments. 
EPR Detection of the ThDP-Enamine Radical 
on E1o-h. The X-band continuous wave EPR 
spectrum of the radical generated by reacting of 
E1o-h (445 µmol concentration of active centers) 
aerobically with 0.5 mM ThDP and 10 mM OG is 
shown in Fig. 4 top.  The spectrum has an overall 
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line shape reminiscent of that previously assigned 
to thiamin-derived radical species: specifically 
C2-hydroxyethylidene-thiamin diphosphate (15) 
and ThDP-enamine radicals (15).  In order to 
determine the validity of the assignment to a 
thiamin-enamine radical for the experimental 
spectrum shown in Fig. 4, we generated spectral 
simulations using parameters (see Experimental 
Procedures) previously assigned for the ThDP-
enamine radical (15). Although the simulation 
depicted in Fig. 4 bottom cannot be considered a 
unique fit at this stage, several points can be made 
regarding the parameters that provide support for 
the structural assignment of the radical.  1) The 
principal g-values used in the simulation are those 
measured for the ThDP-enamine radical using 
High Frequency (HF) EPR (130 GHz) (15). 
Although the X-band (9 GHz) spectrum in Fig. 4 
does not resolve the peaks associated with those g-
values, the spectral position and shape requires a 
g-matrix with similar values and anisotropy to 
those determined for the ThDP-enamine radical.  
Further confirmation of the g-values for the radical 
observed on E1o-h requires an HF-EPR study.  2) 
A large, highly anisotropic nuclear spin = 1 
hyperfine interaction is required to simultaneously 
fit both the low field and high field spectral 
features.  The value used in the simulation in Fig. 
4 is consistent with that used for the 
14
N in the 
ThDP-enamine radical and is diagnostic for 
hyperfine interaction expected for the 
14
N in the 
thiazolium ring.  3) Three to five isotropic 
hyperfine couplings originating from spin= ½ 
nuclei (most likely 
1
H) are required to adequately 
reproduce the spectral shape.  This fit cannot be 
achieved by simply convolving a line-shape 
function with the spectrum generated using the g-
values and 
14
N hyperfine interaction mentioned 
previously.  The requirement of including three to 
five protons with isotropic couplings in the range 
of 3-5 G is consistent with what would be 
expected for -type radical mainly localized to a 
thiazolium cation ring which has β-type protons at 
the various ring positions. The resolution observed 
in the X-band spectrum (Fig. 4) does not allow for 
a more detailed assignment of the protons 
contributing to the spectrum (e.g., whether a CH2-
CH2- moiety has replaced a methyl group at 
the C2  following OG decarboxylation). 
Indeed, a more rigorous assignment of g-values, 
14
N hyperfine values and 
1
H hyperfine values will 
require experiments using HF-EPR, isotopic 
substitution, electron nuclear double resonance 
(ENDOR) and/or electron spin echo envelope 
modulation (ESEEM).  However, the X-band CW 
spectrum and simulation displayed in Fig. 4, 
together with the arguments presented above, 
provide strong support for the assignment of the 
radical species to a ThDP-derived species, likely a 
ThDP-enamineradical.  
   On assembly of OGDHc from equal numbers of 
subunits of E1o-h, E2o-h and E3 components,  the 
thiamin-enamine radical was once more readily 
detected from OG with no CoA present (Figure 4, 
middle), indicating that assembly to OGDHc per 
se does not affect formation of the thiamin-
enamine radical.    
   Radical species were also detected in samples of 
E1o-ec reacted aerobically with both OG and 2-
oxoadipate (OA) in the presence of ThDP.  The 
spectra (not shown), although lower in intensity, 
displayed a line-shape similar to that reported  
previously for E1o-ec (18)
 
and for the E1o-
h/OG/ThDP system studied here (Fig. 4).  The 
E1o-ec EPR spectra are consistent with a ThDP-
enamine-radical species, in agreement with the 
assignment made in the previous EPR/ENDOR 
study of E1o-ec (18) and for E1o-h (Fig. 4). 
   An important further result drawn from the EPR 
studies is the assessment of the concentration of 
ThDP-enamine radicals at the E1o-h and E1o-ec 
active centers. Spin quantification measurements 
determined the amount of radical to be 
approximately (a) 0.9 µM for the E1o-h/OG/ThDP 
system (0.449 mM concentration of E1o-h active 
centers; 0.2% occupancy) (b) ~0.3 µM for both the 
E1o-ec/OG/ThDP and E1o-ec/OA/ThDP systems 
(0.150 mM concentration of E1o-ec active centers; 
0.2% occcupancy) and (c) ~1.3 µM for the 
OGDHc-h assembled from E1o-h, E2o-h and E3 
components (0.222 mM concentration of E1o-h 
active centers; 0.59 % occupancy). It is evident that 
less than 1% of the active centers of E1o-h and 
E1o-ec are occupied by the radical species.  
 
On the ThDP-Bound Intermediate Preceding 
the Thiamin-Enamine Radical. 
(a) Assignment of the Positive CD Band Centered 
near 300 nm to the Second Post-Decarboxylation 
Intermediate. Since both the E1o-h and E1o-ec 
display the same CD behavior with OG (Fig. 2), 
and given the greater stability of the intermediates 
 9 
on E1o-ec, this latter enzyme was used to 
characterize the ThDP-bound intermediate 
responsible for the newly observed CD/VIS signal.  
On incremental addition of OG to E1o-ec, there 
developed two positive CD signals, one at ~ 300, 
the other at ~350 nm (Fig. 2, bottom). The positive 
band near 300 nm could pertain to either pre- or 
post-decarboxylation ThDP-bound intermediate 
with C2-tetrahedral substitution (55).  
   To resolve this ambiguity, a gHSQC NMR 
experiment  was carried out by using [C2,C6‟-
13
C2] 
ThDP labeled E1o-ec similar to that reported 
recently for E1p-ec (43). As was reported earlier, 
the reaction of pyruvate with E1p-ec produces 
C6‟H resonances at 7.34 ppm for C2-
hydroxyethylThDP, and at 7.36, 7.37, and 8.62 
ppm for the keto, hydrate and  carbinolamine 
forms of 2-acetyl-ThDP (43,65,66), when DCPIP 
is present, The 
1
H NMR spectrum of [C2,C6‟-
13
C2] 
ThDP labeled E1o-ec with OG revealed a 
chemical shift of C6‟H at 7.37 ppm (Fig. 5, left)  
corresponding to a C2-hydroxyalkylThDP-like 
compound, C2-(-hydroxy)--carboxypropyl-
ThDP, according to the Tittman-Hübner method 
(65). In the presence of the alternate enamine 
acceptor DCPIP, an external oxidizing agent 
leading to oxidation to 2-succinylThDP, 
1
H 
resonances were observed at 7.37 ppm for the 
C2-hydroxyalkylThDP-like compound and at 
7.47 ppm for the keto/hydrate form of 2-
succinylThDP, probably overlapping with another 
signal (67). (Fig. 5, right). No resonance for the 
tricyclic carbinolamine form of 2-succinylThDP 
could be observed (Fig. 5, right), suggesting that 
the keto/enol form is more stabilized on E1o-ec as 
also observed with another ThDP-dependent 
enzyme POX (67). At later times (above 0.20 s), 
there is a decrease in the area of the resonances 
assigned to 2-succinylThDP, presumably due to 
hydrolysis of succinylThDP, as reported for 
hydrolysis of 2-acetylThDP (43).   
   Formation of C2-(-hydroxy)--carboxypropyl-
ThDP was further confirmed
 
by carrying out the 
reverse reaction. Succinic semialdehyde (SSA) is 
the expected product of non-oxidative 
decarboxylation of OG in the absence of enamine 
oxidation. The [C2,C6‟-
13
C2]ThDP labeled E1o-ec 
was reacted with SSA, followed by acid quench 
and produced a resonance at 7.37 ppm (not 
shown), consistent with that  observed in the 
forward direction and assigned to the second post-
decarboxylation product (C2-(-hydroxy)-
carboxypropylThDP, Scheme 1). The presence of 
C2-(-hydroxy)--carboxypropyl-ThDP in the 
NMR spectrum even after a 3 min incubation of 
E1o-ec with OG suggests stability of the second 
post-decarboxylation intermediate and correlates 
well with the CD results (stability of the positive 
300 nm CD band).       
(b) Assignment of the Positive CD Band at 350 nm 
to the ThDP-Enamine Intermediate. Evidence is 
presented below consistent with the assignment of 
this band to the enamine, the experiments being 
necessitated by our own earlier observations, 
where generation of the enamine derived from 
pyruvate decarboxylation was modeled and gave a 
UV spectrum with λmax 290-295 nm (68), at a 
much shorter wavelength than here seen for OG. 
Pre-steady state rates of formation of ThDP-bound 
intermediates on E1o-ec with OG were determined 
by a stopped-flow CD experiment. To determine 
which of the species giving rise to the CD bands at 
300 nm and 350 nm is formed first, the E1o-ec (38 
µM concentration of active centers)  from one 
syringe was mixed in a reaction cell with OG (4 
mM) from the second syringe, and the reaction 
was monitored for 50 s at 297 nm or at 365 nm 
(two different experiments; the optimal intensity 
of the lamp in the instrument dictates these 
wavelengths as giving the strongest lines nearest 
to the wavelength of interest) (Fig. 6). The 
observed rates of formation of the second post-
decarboxylation intermediate (C2-(-hydroxy)-
carboxypropylThDP in Scheme 1) at 297 nm  is 
0.78 ± 0.02 s-1 (Fig. 6A), while at 365 nm the rates 
are k1 = 2.8 ± 0.1 s
-1
, k1‟ = 0.3 ± 0.01 s
-1
 for the 
biphasic buildup of the enamine intermediate and 
k2 = 0.011 ± 0.008 s
-1
 for its depletion (Fig. 6B). 
These results suggest that formation of the 350 nm 
species is 3-4 times faster than that of the now 
proven second post-decarboxylation intermediate 
at 300 nm, further suggesting that the species 
represented by the CD band at 350 nm is formed 
before the second (C2-tetrahedral) post-
decarboxylation intermediate, consistent with the 
assignment of the 350 nm band to the enamine 
intermediate. This positive CD band has never 
been observed before with either E1o or with any 
other ThDP enzymes. 
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(c) Additional Evidence Supporting the 
Assignment of the Positive CD Band at 350 nm to 
the Enamine Intermediate. One could hypothesize 
three plausible candidates for this transient species 
produced on addition of OG to E1o-h or to E1o-ec 
(Scheme 1, lower right):  the enamine 
intermediate; the one-electron oxidation product of 
the enamine, C2-(-hydroxy)--carboxypropyl-
idene-ThDP radical; or  the two-electron oxidation 
product, 2-succinylThDP (see Scheme 1 for an 
explanation of intermediates).  The following 
arguments support the formation of the enamine 
intermediate:   
   (i) Observation of the ThDP-enamine radical 
with less than 1% of active center occupancy (i.e., 
sub-M concentration) rules out the radical, as the 
CD instrumentation employed is incapable of 
observing such low amounts by either steady-state 
of time-resolved methods.  
   (ii) The recent report of the observation of a CD 
band near 390-395 nm for 2-acetylThDP tends to 
rule out 2-succinylThDP, as it should have a 
characteristic CD signal near that of 2-acetylThDP 
(69).    
   (iii) The 
1
H NMR spectrum of [C2,C6‟-
13
C2] 
ThDP labeled E1o-ec with OG revealed a 
chemical shift of C6‟H at 7.37 ppm (Fig. 5, left)  
corresponding to a C2-hydroxyalkylThDP-like 
compound, C2-(-hydroxy)--carboxypropyl-
ThDP (second post-decarboxylation  product), a 
result of C2-protonation of the enamine (Scheme 
1, right).  
   (iv) We then hypothesized that the presence of 
an alternate electrophilic acceptor for the putative 
enamine would change the kinetics of build-up 
and/or depletion of the CD band corresponding to 
the intermediate. The following potential enamine 
acceptors were tested: (i) As mimic of the 
physiological reaction, the E2o-ec derived 
didomain was used (E2o-ec
1-176
, comprising from 
the N-terminus, the lipoyl domain, the peripheral 
subunit binding domain, and linkers); (ii) DCPIP 
was used as an external oxidizing agent; and 
finally (iii) Glyoxylate was used as a known 
enamine acceptor in a so-called „carboligase‟ 
reaction (33,70,71). As control, stopped-flow CD 
experiment of E1o-ec with OG was carried out and 
displayed relatively good stability of the 365 nm 
signal (Fig. 7a). It is evident from comparing the 
data on Fig. 7 (7a, 7b, 7c, and 7d) that the three 
acceptors (DCPIP, glyoxylate, and E2o-ec
1-176 
didomain) shortened the lifetime of the species 
corresponding to the 365 nm CD band, consistent 
of it being pertinent to the ThDP-enamine.  
  (v) An UV-VIS stopped-flow photodiode array 
(PDA) experiment was carried out by mixing E1o-
ec with OG (Fig. 8) and resolved several issues: (I) 
From the experience gained in CD studies of 12 
ThDP enzymes so far, when there is a strong 
UV/VIS signal observable along with the CD band 
at the same wavelength, a conjugated system is the 
source of the electronic transition, rather than a 
charge transfer band, whose λmax is not predictable 
with current theory. (II) Unexpectedly, the PDA 
experiment could resolve two species with λmax at 
348 and 361 nm and a clean isosbestic point (Fig. 
8, top); with time, the species monitored at 348 nm 
diminishes, while the one at 361 nm increases in 
amplitude (Fig. 8, bottom). Recognizing that these 
species correspond to a post-decarboxylation 
intermediate(s), two possible explanations could 
be envisioned once more: (1) Perhaps, the ThDP-
enamine and the ThDP-enamine radical (Scheme 
1) have uncannily similar λmax values, where the 
λmax at 348 nm corresponds to the former, that is 
converted to the radical with longer λmax. (2) Both 
species are ThDP-enamines, perhaps in different 
conformations/configurations. Several arguments 
favor the second explanation. The species at 348 
nm is fully formed at the first time point (Fig. 8, 
bottom), consistent with the time-resolved CD 
behavior, while the formation of the species at 361 
has a significant lag time. Also, the recently 
published X-ray structure of 2-oxoglutarate 
decarboxylase (72) from Mycobacterium 
smegmatis with OG (this enzyme is sometimes 
referred to as E1o in Mycobacterium smegmatis), 
and 2-hydroxy-3-ketoadipate synthase in 
Mycobacterium tuberculosis (66), suggested the 
existence of two enamines (post-decarboxylation 
intermediates), the authors termed early and late 
(72), the „early‟ one converted with time to the 
„late‟ one. 
(vi) While OG added to E1o-ec gave rise to this 
CD band near 350 nm, the related 2-oxo acids with 
no side chain carboxyl groups, 2-oxovalerate and 
2-oxoisovalerate, did not (not shown) (70). 
   The cumulative evidence points to the ThDP-
enamine as the species responsible for the newly 
identified electronic transition near 350 nm 
produced by OG on E1o-h and E1o-ec. Possible 
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explanations of the λmax observed are in Scheme 2, 
but whatever is the correct explanation, it must 
involve a longer conjugated system than present in 
the ThDP-enamine derived from pyruvate. 
Evidence for Reactive Oxygen Species 
Production by E1o-h. Generation of ROS by 
E1o-h was detected by two independent and 
widely used methods: the Amplex Red 
fluorescence assay for detection of H2O2 and the 
acetylated cyt c reduction assay for detection of 
superoxide anion. The assays verified superoxide 
and H2O2 generation by E1o-h and exhibited 
quantitatively the same order of magnitude 
specific activity (Fig. 9). An E1o-h specific 
activity of 4.45±0.41 nmol.min-1 mg E1o-h-1 (n=3) 
(pH 7.3) and 4.05±0.10 nmol.min-1.mg E1o-h-1 
(n=3) (pH 6.3) was determined for H2O2 
generation, with no statistically significant 
difference detected between the results at the two 
pH values. The E1o-h specific activity for 
superoxide generation was 2.06±0.07 nmol.min-
1
.mg E1o-h
-1
 (n=5) (pH 6.3). No statistically 
significant difference in activity was found when 
the pH was changed from 7.3 to 6.3 (measured in 
the Amplex Red assay). These values were 
compared to the specific activity of the E1o-h, as 
an isolated component, or as part of OGDHc 
assembled from individual components (Table 1). 
The comparison shows that the ROS generation 
capacity by E1o-h is 0.23% for H2O2 and 0.12% 
for superoxide as compared with the E1o-h 
specific activity measured in the DCPIP assay. 
     As the primary product is proposed to be 
superoxide (a one-electron reduction of O2 to O2
-
 
according to eq. 2), the H2O2 present in the assay 
could be considered to be the product of  
spontaneous dismutation (disproportionation) of 
superoxide (6, 21, 23, 73), similar to that reported 
for other enzymes (74), rather than two-electron 
reduction of O2 to H2O2 according to eq. 3:  
 
Enzyme-H2 + 2O2 → Enzyme + 2H
+
 + 2 O2
-
 (2) 
Enzyme-H2 +   O2 →Enzyme + H2O2            (3) 
 
 In support of this conclusion we present the 
following:  
 (a) As one electron enamine oxidation on E1o-h 
leading to enamine-derived radical was detected 
by the EPR experiment, a one electron reduction 
of O2 leading to superoxide is logical. (b) The 
production of superoxide by E1o-h was directly 
detected by the cyt c assay; (c) In control 
experiment, the superoxide dismutase when added  
in the cyt c assay ,completely eliminated the signal 
by trapping superoxide produced by E1o-h ; (d) 
When catalase was added to Amplex Red assay in 
a similar control experiment, the signal was also 
eliminated, confirming H2O2 accumulation in the  
Amplex Red assay. 
   An additional control experiments were carried 
out to confirm ROS generation by E1o-h: (i) In the 
Amplex Red assay neither OG nor E1o-h revealed 
H2O2 production by itself in the presence of Mg
2+
, 
ThDP, ADP and CoA. Further, the order of 
addition of OG or E1o-h did not change the 
experimental results beyond experimental error. 
(ii) The Amplex Red assay was also tested using 
commercial   porcine heart OGDHc (Sigma, St. 
Louis, MO) and the reported earlier protocol (6), 
leading to the observation that the rate of H2O2 
generation by porcine heart OGDHc was in a good 
accord with that reported earlier.  Nevertheless, a 
direct quantitative comparison was not reliable 
because of the impurities present in the 
commercial  OGDHc preparations. 
   Next, we estimated the rate of spontaneous 
dismutation reaction under the assay conditions as 
following:  
(i) With E1o-h activity of 2.06 nmol.min
-1
.mg 
E1o
-1
 for superoxide production, a kcat = 0.0076 s
-1
 
(first order rate constant) and an O2
-
 concentration 
of ~1x10
-5
M could be estimated. 
(ii) If no cyt c is present in the assay medium, a 
second order rate constant for spontaneous 
dismutation of O2
-
 of 2 x10
5
 M
-1
 s
-1
 (pH 7.3) was 
estimated based on a rate constant of 2x10
5
 M
-1
.s
-1
 
(pH 7.4) reported in the literature (ref 73), yielding 
a first order rate constant of 2 s
-1
. 
(iii) When cyt c is present in the assay, using a k 
of 3.5 x 10
5
 M
-1
 s
-1
 (pH ~7.0), (ref 74), for the 
same concentration of O2
-
,
 
the value of 3.5 s
-1 
is 
estimated.  
From these simple estimates we conclude that 
superoxide formation by E1o-h is the rate-limiting 
step (7.6x10
-3
 s
-1
), while spontaneous dismutation 
to H2O2 (2 s
-1
) or reaction of HO2/O2
-
 with 
acetylated cyt c (3.5 s
-1
) are both much faster and 
have nearly equal probability.  
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   At present, the functional relevance of ROS 
generation by OGDHc-h under various 
pathological conditions has been proven and is 
discussed in detail in the literature, partly by the 
Semmelweis group and others (4-6,19-
22,30,31,75-78). In theory, E1o-h could generate 
the same amount of superoxide as the entire 
OGDHc functioning in the mitochondrion based 
on data presented in this paper and in the 
literature. However, a direct comparison of ROS 
production by OGDHc on isolated mitochondria 
with data presented in this paper on E1o-h is not 
possible, since these values were calculated per 
total protein but not per amount of OGDHc 
content. A reasonably relevant comparison is with 
OGDHc isolated from pig heart providing a 
superoxide producing activity of 1 nmol.min
-1
.mg 
protein
-1
 in both the physiological reaction (with 
OG and CoA) and in the reverse reaction with 
NADH. This reaction was attributed to E3-h in the 
OGDHc and constituted 0.3-0.4% of the overall 
OGDHc reaction (20). 
    
   Recently, the relative maximum capacities for 
O2
-
/H2O2 generation were compared for 
NADH/NAD+ dependent enzyme complexes in 
intact skeletal muscle mitochondria. The studies 
revealed that under optimal conditions, the 
OGDHc produced superoxide/H2O2 at about twice 
the rate from PDHc, and at four times the rate 
from BCOADHc (when oxidizing their specific 2-
oxoacid substrates in the physiological reaction), 
and at eight times the rate from respiratory 
complex site IF., indicating that OGDHc has the 
highest capacity in this group (19). 
 
 
SUMMARY and CONCLUSIONS 
The first successful expression and purification of 
active, full-length E1o and E2o components of the 
human 2-oxoglutarate dehydrogenase multi-
enzyme complex enabled this collaborative effort 
to undertake studies directed to an elucidation of 
the fundamental reactions carried out by this 
enzyme complex. (a) Formation of a ThDP-
enamine radical was demonstrated by EPR 
spectroscopy generated from OG, for both the 
human and E. coli E1o components, and for 
OGDHc-h reconstituted from the three component 
enzymes, as shown for the E1o-ec earlier (18). 
How and whether this radical, formed by reaction 
of dioxygen with the enamine, receives special 
stabilization remains to be determined. (b) On 
addition of OG to E1o-h and E1o-ec a new 
electronic transition was observed centered at 350 
nm by both UV-VIS and CD spectroscopy. 
Multiple experiments are suggestive of the 
transition being pertinent to the ThDP-enamine 
intermediate – the first ThDP-bound post-
decarboxylation intermediate in Scheme 1. The 
stability of the ThDP-enamine, compared to that 
derived from pyruvate, is more than likely due to 
some stabilization afforded by the side chain C5 
carboxylate group (Scheme 2), perhaps of the 
enaminolate oxyanionic forming an intramolecular 
hydrogen bond, or of the lone pair of electrons at 
C2 in the enamine forming an intramolecular 
hydrogen bond. Either scenario is difficult to 
model, unlike the enaminol form derived from 
pyruvate, where it was modeled by replacing an 
OH group by an OCH3 group (68). (c) Of greatest 
import to human physiology and pathology, the 
E1o-h component now joins the E3-h component 
as being able to generate superoxide anion, and 
thence hydrogen peroxide probably by 
dismutation, shown here for the first time. The 
specific activity on this pathway is 0.1-0.2% of the 
physiological activity, certainly significant. Here 
both products formed in Equation 1 are clearly 
demonstrated for E1o-h, adding to the important 
differences in the aerobic behavior between the 
pyruvate and 2-oxoglutarate dehydrogenase 
complexes. The importance of superoxide 
formation from E1o-h under physiological 
conditions remains to be demonstrated on the 
human OGDHc. 
    Finally, the ability to assess the fractional 
occupancy of active sites by the ThDP-enamine 
radical, as well as the fractional specific activity of 
ROS formation compared to NADH production, 
allows us to conclude that the O2-induced 
oxidation-reduction chemistry in Eq 1 is „off-
pathway‟ at much less than 1% of the „on-
pathway‟ reactivity of the enamine towards 
reductive succinylation of E2o, thence succinyl-
CoA formation. Therefore, there is little likelihood 
that the principal pathway follows a radical 
mechanism for the reductive acylation of the 
lipoyl-E2. The low occupancy of E1o active 
centers by the thiamin enamine radical suggests 
that the on-pathway mechanism produces 
succinyl-CoA via 2-electron enamine oxidation 
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(ionic mechanism) proposed in a model reaction 
(79).
 
 
  
Supporting Information. Two SI Tables S1 and 
S2 on peptic digests of E1o-h and E2o-h. This 
material is available free of charge via the internet. 
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FIGURE LEGENDS 
 
Figure 1. Kinetic parameters for human OGDHc. Top. Dependence of the OGDHc activity on 
concentration of OG. The OGDHc was assembled from E1o-h, E2o-h and E3 components at mass ratio 
(g:g:g) of 1:5:5 corresponding to concentration of subunits: E1o-h (0.046 M), E2o-h (0.60 M) and 
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E3 (0.52 M). For experimental details, see Experimental Procedures. Data were fitted to a Hill equation 
(vo = vo
max
 . [OG]
n
 / (S 0.5
n
 + [OG]
n
), and the trace is the regression fit line. The nH = 0.92 ± 0.08. 
Bottom. pH dependence of OGDHc activity. The reaction was carried out in 0.1 M Tris.HCl in the pH 
range of 6.5-9.3.  For details on OGDHc assembly and activity measurement see Experimental 
Procedures. The values of activity were plotted to a curve defined by one ionizing group according to log 
(activity) = log (activity
max
) - log (1+ 10 
(x-pKa
1
)
), where x is the value of pH. 
Figure 2. Circular dichroism titration of E1o-h and E1o-ec by OG. (Top) E1o-h (18 M active center 
concentration) in 50 mM KH2PO4 (pH 7.5) containing 0.20 mM ThDP and 1.0 mM MgCl2 was titrated by 
OG (10-500 M) at 4 oC. (Bottom) E1o-ec (20 M active center concentration) was titrated by OG (0.05-
6 mM) in 20 mM KH2PO4 (pH 7.0) containing 150 mM NaCl, 0.2 mM ThDP and 1 mM MgCl2 at 20 
o
C.  
Figure 3.  Circular dichroism titration of E1o-h by succinylphosphonate. (Top) The E1o-h (1.68 mg/ml, 
concentration of active centers = 14.9 M) in 20 mM KH2PO4 (pH 7.5) containing 0.2 mM ThDP and 2.0 
mM MgCl2 was titrated by succinylphosphonate (1-130 M). Two CD bands observed could be assign to 
1‟,4‟-iminotautomer of the first pre-decarboxylation intermediate  (positive CD band at 304 nm)  ,and  to 
the Michaelis complex (negative CD band at 342 nm). (Bottom) The dependence of the CD at 342 nm on 
concentration of succinylphosphonate leading to S 0.5, succinylphosphonate of 20 ±5 M. Data were fitted to a 
Hill equation (CDo = CDo
max
 . [SP]
n
 / (S 0.5
n
 + [SP]
n
), and the trace is the regression fit line. The nH = 0.86 
± 0.11.  
Figure 4. X-band (9 GHz) EPR spectra of the radical species generated in the E1o-h (top) and in the 
human OGDH complex (middle) along with a spectral simulation (bottom). Top:  E1o-h (concentration of 
active centers = 0.449 mM ) in 0.4 mL of 50 mM HEPES (pH 7.5) containing 0.15 M NaCl, 0.50 mM 
ThDP and 1.0 mM MgCl2 was mixed with 10 mM OG at room temperature.  The mixture was 
immediately transferred into an EPR tube and was flash-frozen in liquid nitrogen within 40 s of mixing all 
components. Middle:  E1o-h, E2o-h and E3 components were mixed at concentration of subunits of 0.222 
mM for each of the three components in 50 mM HEPES (pH 7.5) containing 0.50 mM ThDP, 2.0 mM 
MgCl2 and  0.15 M NaCl. Reaction was started by addition of 10 mM OG and sample was treated the 
same way as E1o-h above. Parameters used for the acquisition of the experimental spectra are presented 
under the Experimental Procedures.  Bottom:  The parameters used for the simulation are consistent with 
the ThDP-enamine radical species (for details see Experimental Procedures).  
 
Figure 5.  Distribution of ThDP-bound covalent intermediates in the reaction of E1o-ec. gCHSQC NMR 
spectra of the supernatant after acid quench of the E1o-ec reaction and removal of protein from the 
reaction. The [C2, C6‟-
13
C2] ThDP labeled E1o-ec was incubated with OG for 50 ms in the absence (left) 
and in the presence of DCPIP (right). The C6‟H chemical shift of 8.01, 7.37 and 7.47 ppm corresponds to 
ThDP, C2-(-hydroxy)--carboxypropyl-ThDP and succinylThDP, respectively. The 7.36-7.37 ppm 
resonance has contributions from both species.  
Figure 6.  Pre-steady state kinetics of E1o-ec with OG.  A. Time-dependence of buildup of the C2-(-
hydroxy)- carboxypropyl ThDP intermediate (second post-decarboxylation intermediate in Scheme 1). 
The data points were fit using a single exponential equation (CD297
(t)
 = CD1 . e
-k
1
t
 + c), and the line is  a 
regression fit trace. B. Time-dependence of enamine formation on E1o-ec. The data were fitted using the 
triple exponential equation (CDλ 
(t)
 = CD1. e
-k
1
t
 + CD2. e
-k
1‟
t
 - CD2. e
-k
2
t
 + c), and the line is the regression 
fit trace. The k1, k-1, and k2 are the apparent rate constants; c,  CD
max
λ in the exponential rise to maximum 
model. All stopped-flow CD experiments were performed in 20 mM KH2PO4 (pH 7.0) with 0.5 mM 
ThDP and 2 mM MgCl2 at 20 
o
C. 
Figure 7.  Effect of different enamine acceptors on the CD at 365 nm. (a) Stopped-flow CD behavior at 
365 nm where E1o-ec from one syringe was mixed with 100 µM OG from the second syringe at 20 oC. In 
the other traces E1o (38 µM active sites concentration) from one syringe was mixed with the enamine 
acceptor (concentration mentioned in the figure) premixed with OG in the second syringe: (b) E2o-ec
1-176
 
didomain (DD), (c) DCPIP, (d) glyoxylate. 
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Figure 8. Reaction of E1o-ec with OG monitored by stopped-flow PDA. (Top) E1o-ec spectra with 10 
mM OG showing formation of ThDP-enamines, perhaps in different conformations/configurations. E1o-
ec (40 µM concentration of active centers) was mixed with equal volume of 10 mM OG in the same 
buffer at 25 
o
C. Reaction was monitored in the 280-400 nm wavelength range for 500 s. (Bottom) Time 
course of the formation of ThDP-enamines at the indicated wavelength. 
Figure 9. Superoxide/H2O2 production by E1o-h. A. Superoxide/H2O2 production by E1o-h as measured 
by the cytochrome c (cyt c) or the Amplex Red assay and expressed as the amount of superoxide or H2O2 
produced (pmol).min
-1
.mg E1o-h
-1
. Linear fitting to initial velocity data points generated always an 
R
2
>0.982 in the cyt c assay or greater in the Amplex Red assay. The primary data were corrected with the 
average slopes of the blanks (for both assays). Error bars represent S.E.M. values for five (cyt c assay) or 
three (Amplex Red assay) parallel measurements. No statistically significant difference was found 
between the rates of H2O2 production measured at two different pH values by the Amplex Red assay. For 
experimental conditions see Experimental Procedures. B. Representative Amplex Red fluorescence traces 
for H2O2-generation by E1o-h at different pH values with additions indicated. For experimental 
conditions see Experimental Procedures.  Curves have been offset for clarity. For calibration of all 
experiments (designated as “cal” in bottom figure, 100 pmol of H2O2 was applied in duplicates. 1 mM 
NAD
+
 was added to the reaction assay at pH 7.3. 
 
 
 
 
 
 
 
 
 
 
Table 1 The Kinetic Parameters of Human OGDHc. 
Overall OGDHc  activity  
(mol. min-1.mg E1o-1)a 
  kcat/Km 
 (s
-1.
 mM 
-1
) 
 E1o-h specific assay 
(mol.min-1.mg E1o-h-1) 
ROS activity (pH=6.3) 
nmol.min
-1
.mg E1o-h
-1
 
         7.86 ± 0.74  
        (kcat = 30 s
-1
) 
         
     200        1.78 ±0.40 
       (kcat = 6.7 s
-1
) 
 H2O2   4.05 ± 0.10
b
 
 O2
.-
      2.06 ± 0.07 
a
Steady state kinetic results obtained at pH of 7.5; see details under Experimental Procedures. 
b
H2O2 
generation at pH 7.3 was found to be quantitatively very similar to the value at pH 6.3 (4.45 ± 0.41 
nmol.min
-1
.mg E1o-h
-1
). 
 
 
 
                            . 
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 Scheme 1. Mechanism of OGDHc with alternative fates of the enamine. 
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Scheme 2.  Possible role of side chain carboxylate in stabilizing ThDP-bound enamine and radical.  
 
 
 
 
 
 
 
 
 
 
 
 
 
